Seeing Is Believing
with an average price target of $6.13. This is a potential upside of $3.04 (98.38%) from yesterday's end of day stock price of $3.09.
Eliem Therapeutics's activity chart (see below) currently has 12 price targets and 13 ratings on display.
Analysts average stock forecasts to be materialized ratio is 45.83% with an average time for these price targets to be met of 381.5 days.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 07-Mar-2023. First documented stock forecast 06-Sep-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6
$2.91 (94.17%)
2 years 7 months 19 days ago
(07-Mar-2023)
2/2 (100%)
$2.36 (64.84%)
485
Buy
$4
$0.91 (29.45%)
$9
3 years 2 months 11 days ago
(15-Aug-2022)
2/4 (50%)
$1.11 (38.41%)
402
Buy
$8
$4.91 (158.90%)
3 years 2 months 25 days ago
(01-Aug-2022)
1/3 (33.33%)
$5.28 (194.12%)
639
Hold
$32
3 years 6 months 1 days ago
(25-Apr-2022)
0/1 (0%)
$3.39 (11.85%)
What is ELYM (Eliem Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ELYM (Eliem Therapeutics) with a proven track record?
Which analyst has the current lower performing score on ELYM (Eliem Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ELYM (Eliem Therapeutics)?
Which analyst is the currently most bullish on ELYM (Eliem Therapeutics)?
Which analyst is the currently most reserved on ELYM (Eliem Therapeutics)?